Business
C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances
C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances
About this update from C-rad Ab Class B
C-RAD AB (publ), a global leader in Surface Guided Radiation Therapy (SGRT), is attending ESTRO 2026 in Stockholm with live demonstrations of its flagship Catalyst⁺ HD, including targeted workflow and interface improvements developed in close collaboration with the clinical community. Together, these reflect a renewed strategic direction for C-RAD: focused, customer-led innovation built around what clinicians have asked for and what treatment rooms actually need.Trusted by leading cancer centers worldwide, Catalyst+ HD sets the standard for SGRT. Catalyst+ HD offers the largest field of view in SGRT — a hip-to-head surface capture treated as a single, continuous region of interest, making the system both highly versatile and future-proof. Structured light technology enables color projection directly onto the patient’s skin for intuitive, lighting-independent positioning, while non-rigid registration removes the need for manual region-of-interest definition entirely. At ESTRO 2026, C-RAD will also demonstrate two workflow updates developed directly from clinical feedback. The large field of view enables a new ergonomic setup workflow that guides patients into alignment before fine positioning begins creating a smoother, more efficient experience for both patient and clinician. This is accompanied by a redesigned user interface built to improve clarity and reduce cognitive load in busy treatment environments.Catalyst+ LITE, the newest member of the Catalyst⁺ family, addresses a gap that has held many clinics back: how to adopt SGRT without committing to a full-scale system from day one. Delivering high-precision motion management and tattoo-less patient setup, its modular architecture allows clinics to start with a robust foundational system and upgrade seamlessly to Catalyst⁺ HD as their needs evolve — without hardware replacement. Together, the Catalyst⁺ family provides a clear path for any clinic looking to adopt or deepen their SGRT practice.Additionally, C-RAD is offering dedicated Meet the Expert sessions at ESTRO 2026 — an opportunity for clinicians to explore the clinical benefits of SGRT in a focused, individual setting, ask questions relevant to their specific workflows, and speak directly with C-RAD’s product and clinical specialists.Tomas Blomquist, CEO of C-RAD AB (publ), comments on the company’s direction:“ESTRO 2026, hosted this year in our ...